Summary
Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences.
Market Segment as follows:
By Type
Long-lasting Type
Ordinary Type
By Application
Hepatitis C
Hepatitis B
Others
By Company
Roche
Biosidus
Zydus Cadila
Nanogen
Amega Biotech
Rhein Minapharm Biogenetics
PROBIOMED
3sbio
The main contents of the report including:
Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by type;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Interested in this report?
Get your sample now!
Table of Content
1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Long-lasting Type
1.1.2.2 Ordinary Type
1.1.3 Market by Application
1.1.3.1 Hepatitis C
1.1.3.2 Hepatitis B
1.1.3.3 Others
1.2 Global and China Market Size
1.2.1 Global Overview
1.2.2 China Overview
2 Global and China Market by Company
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 China
2.2.1 China Sales by Company
2.2.2 China Price by Company
3 Global and China Market by Type
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 China
3.2.1 China Sales by Type
3.2.2 China Price by Type
4 Global and China Market by Application
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 China
4.2.1 China Sales by Application
4.2.2 China Price by Application
5 China Trade
5.1 Export
5.2 Import
6 Key Manufacturers
6.1 Roche
6.1.1 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Biosidus
6.3 Zydus Cadila
6.4 Nanogen
6.5 Amega Biotech
6.6 Rhein Minapharm Biogenetics
6.7 PROBIOMED
6.8 3sbio
7 Industry Upstream
7.1 Industry Chain
7.2 Raw Materials
8 Market Environment
8.1 SWOT
8.2 Porter's Five Forces
9 Conclusion
Figure Long-lasting Type Market Size and CAGR 2013-2018 (Million USD)
Figure Long-lasting Type Market Size and CAGR 2013-2018 (Volume)
Figure Long-lasting Type Market Forecast and CAGR 2019-2025 (Million USD)
Figure Long-lasting Type Market Forecast and CAGR 2019-2025 (Volume)
Figure Ordinary Type Market Size and CAGR 2013-2018 (Million USD)
Figure Ordinary Type Market Size and CAGR 2013-2018 (Volume)
Figure Ordinary Type Market Forecast and CAGR 2019-2025 (Million USD)
Figure Ordinary Type Market Forecast and CAGR 2019-2025 (Volume)
Figure Hepatitis C Market Size and CAGR 2013-2018 (Million USD)
Figure Hepatitis C Market Size and CAGR 2013-2018 (Volume)
Figure Hepatitis C Market Forecast and CAGR 2019-2025 (Million USD)
Figure Hepatitis C Market Forecast and CAGR 2019-2025 (Volume)
Figure Hepatitis B Market Size and CAGR 2013-2018 (Million USD)
Figure Hepatitis B Market Size and CAGR 2013-2018 (Volume)
Figure Hepatitis B Market Forecast and CAGR 2019-2025 (Million USD)
Figure Hepatitis B Market Forecast and CAGR 2019-2025 (Volume)
Figure Others Market Size and CAGR 2013-2018 (Million USD)
Figure Others Market Size and CAGR 2013-2018 (Volume)
Figure Others Market Forecast and CAGR 2019-2025 (Million USD)
Figure Others Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Interferon Alpha-2a Biosimilar Market Size and CAGR 2013-2017 (Million USD)
Figure Global Interferon Alpha-2a Biosimilar Market Size and CAGR 2013-2017 (Volume)
Figure Global Interferon Alpha-2a Biosimilar Market Forecast and CAGR 2019-2025 (Million USD)
Figure Global Interferon Alpha-2a Biosimilar Market Forecast and CAGR 2019-2025 (Volume)
Figure China Interferon Alpha-2a Biosimilar Market Size and CAGR 2013-2017 (Million USD)
Figure China Interferon Alpha-2a Biosimilar Market Size and CAGR 2013-2017 (Volume)
Figure China Interferon Alpha-2a Biosimilar Market Forecast and CAGR 2019-2025 (Million USD)
Figure China Interferon Alpha-2a Biosimilar Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure China Market Sales Revenue Share by Company in 2017
Figure China Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure China Market Sales Revenue Share by Type in 2017
Figure China Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure China Market Sales Revenue Share by Application in 2017
Figure China Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Interferon Alpha-2a Biosimilar SWOT List
Figure Interferon Alpha-2a Biosimilar Porter's Five Forces
